Searching for BRCA3 by exome sequencing

by Makunin I, Stark M, Gartside M, Chenevix-Trench G
Published 2012-04-01

The use of the Illumina FFPE Restoration Protocol to obtain suitable quality DNA for SNP-based CGH– a pilot study

by Hosein AN, Cocciardi S, Jayanthan J, Song S, Simpson P, Chenevix-Trench G
Published 2012-04-01

Common genomic variants associated with breast cancer predict the risk of second primary breast cancer diagnosis

by Sawyer S, McKinley J, Mitchell G, Chenevix-Trench G, Harris M, Lindeman G, James PA
Published 2012-04-01

A multi-center study to evaluate the impact of germline BRCA1 and BRCA2 mutations on ovarian cancer survival

by Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Gayther SA, Chanock SJ, Antoniou AC, Pharoah PDP
Published 2012-04-01

Primary treatment patterns in women recruited to the Australian Ovarian Cancer Study

by Hung J, Fereday S, Harnett P, Giles D, Gao B, Traficante N, Chenevix-Trench G, Green A, Webb P, Bowtell D, DeFazio A
Published 2012-04-01

The challenges of finding the gene responsible for a rare, autosomal dominant gastric cancer susceptibility syndrome

by Li JJ, Healey S, Phillips K, Makunin I, Wayte N, Schrader I, Worthley D, Lindor N, Huntsman D, Goldgar D, Suthers G, Chenevix-Trench G
Published 2012-04-01

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients

by Thompson ER, Boyle SE, Johnson J, Ryland GL, Sawyer S, Choong DY, Chenevix-Trench G, Trainer AH, Lindeman GJ, Mitchell G, James PA, Campbell IG
Published 2012-04-01

The Australian Ovarian Cancer Study

by Traficante N, Fereday S, Galletta L, Hung J, Giles D, Alsop K, Hendley J, Iuga A, Chenevix-Trench G, Green A, Webb P, DeFazio A, Bowtell D
Published 2012-04-01

Identification of new breast cancer predisposition genes via whole exome sequencing

by Southey MC, Park DJ, Lesueur F, Odefrey F, Nguyen-Dumont T, Hammet F, Neuhausen SL, John EM, Andrulis IL, Chenevix-Trench G, Baglietto L, Le Calvez-Kelm F, Pertesi M, Lonie A, Pope B, Sinilnikova O, Tsimiklis H, Giles GG, Hopper JL, Tavtigian SV, Goldgar DE
Published 2012-04-01

Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

by Easton, D.F., Pharoah, P.D.P., Antoniou, A.C., Tischkowitz, M., Tavtigian, S.V., Nathanson, K.L., Devilee, P., Meindl, A., Couch, F.J., Southey, M., Goldgar, D.E., Evans, G.R., Chenevix-Trench, G., Rahman, N., Robson, M., Domchek, S.M., Foulkes, W.D.
Published 2015

More on Co-Occurrence of COMT and BRCA1/2 Variants in a Population

by Chenevix-Trench, G, Barnes, DR, Antoniou, AC
Published 2017

COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration

by Southey, M.C., Park, D.J., Nguyen-Dumont, T., Campbell, I., Thompson, E., Trainer, A.H., Chenevix-Trench, G., Simard, J., Dumont, M., Soucy, P., Thomassen, M., Jonson, L., Pedersen, I.S., Hansen, T.V.O., Nevanlinna, H., Khan, S., Sinilnikova, O., Mazoyer, S., Lesueur, F., Damiola, F., Schmutzler, R., Meindl, A., Hahnen, E., Dufault, M.R., Chan, T.C., Kwong, A., Barkardottir, R., Radice, P., Peterlongo, P., Devilee, P., Hilbers, F., Benitez, J., Kvist, A., Torngren, T., Easton, D., Hunter, D., Lindstrom, S., Kraft, P., Zheng, W., Gao, Y.T., Long, J., Ramus, S., Feng, B.J., Weitzel, R.N., Nathanson, K., Offit, K., Joseph, V., Robson, M., Schrader, K., Wang, S.M., Kim, Y.C., Lynch, H., Snyder, C., Tavtigian, S., Neuhausen, S., Couch, F.J., Goldgar, D.E.
Published 2013

Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

by Baxter, JS, Johnson, N, Tomczyk, K, Gillespie, A, Maguire, S, Brough, R, Fachal, L, Michailidou, K, Bolla, MK, Wang, Q, Dennis, J, Ahearn, TU, Andrulis, IL, Anton-Culver, H, Antonenkova, NN, Arndt, V, Aronson, KJ, Augustinsson, A, Becher, H, Beckmann, MW, Behrens, S, Benitez, J, Bermisheva, M, Bogdanova, NV, Bojesen, SE, Brenner, H, Brucker, SY, Cai, Q, Campa, D, Canzian, F, Castelao, JE, Chan, TL, Chang-Claude, J, Chanock, SJ, Chenevix-Trench, G, Choi, JY, Clarke, CL, Colonna, S, Conroy, DM, Couch, FJ, Cox, A, Cross, SS, Czene, K, Daly, MB, Devilee, P, Dörk, T, Dossus, L, Dwek, M, Eccles, DM, Ekici, AB, Eliassen, AH, Engel, C, Fasching, PA, Figueroa, J, Flyger, H, Gago-Dominguez, M, Gao, C, García-Closas, M, García-Sáenz, JA, Ghoussaini, M, Giles, GG, Goldberg, MS, González-Neira, A, Guénel, P, Gündert, M, Haeberle, L, Hahnen, E, Haiman, CA, Hall, P, Hamann, U, Hartman, M, Hatse, S, Hauke, J, Hollestelle, A, Hoppe, R, Hopper, JL, Hou, MF, Ito, H, Iwasaki, M, Jager, A, Jakubowska, A, Janni, W, John, EM, Joseph, V, Jung, A, Kaaks, R, Kang, D, Keeman, R, Khusnutdinova, E, Kim, SW, Kosma, VM, Kraft, P, Kristensen, VN, Kubelka-Sabit, K, Kurian, AW, Kwong, A, Lacey, JV, Lambrechts, D, Larson, NL, Larsson, SC
Published 2021

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

by Li, Jingmei, Lei, Jieping, Rudolph, Anja, Moysich, Kirsten Barbara, Rafiq, Sajjad, Behrens, Sabine, Goode, Ellen L., Pharoah, Paul D P, Seibold, Petra, Fasching, Peter Andreas Ndreas, Andrulis, Irene Louise Irene L, Kristensen V.N., Couch F.J., Hamann U., Hooning M.J., Nevanlinna H., Eilber U., Bolla M.K., Dennis J., Wang Q., Lindblom A., Mannermaa A., Lambrechts D., Garcia-Closas M., Hall P., Chenevix-Trench G., Shah M., Luben R., Haeberle L., Ekici A.B., Beckmann M.W., Knight J.A., Glendon G., Tchatchou S., Alnaes G.I.G., Borresen-Dale A.-L., Nord S., Olson J.E., Hallberg E., Vachon C., Torres D., Ulmer H.-U., Rudiger T., Jager A., van Deurzen C.H.M., Tilanus-Linthorst M.M.A., Muranen T.A., Aittomaki K., Blomqvist C., Margolin S., Kosma V.-M., Hartikainen J.M., Kataja V., Hatse S., Wildiers H., Smeets A., Figueroa J., Chanock S.J., Lissowska J.,Humphreys K., Phillips K.-A., Linn S., Cornelissen S., van den Broek S.A.J., Kang D., Choi J.-Y., Park S.K., Yoo K.-Y., Hsiung C.-N., Wu P.-E., Hou M.-F., Shen C.-Y., Teo S.H., Taib N.A.M., Yip C.H., Ho G.F., Matsuo K., Ito H., Iwata H., Tajima K., Dunning A.M., Benitez J., Czene K., Sucheston L.E., Maishman T., Tapper W.J., Eccles D., Easton D.F., Schmidt M.K., Chang-Claude J.
Published 2016

Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers

by Spurdle, A.B., Marquart, L., McGuffog, L., Healey, S., Sinilnikova, O., Wan, F., Chen, X.Q., Beesley, J., Singer, C.F., Dressler, A.C., Gschwantler-Kaulich, D., Blum, J.L., Tung, N., Weitzel, J., Lynch, H., Garber, J., Easton, D.F., Peock, S., Cook, M., Oliver, C.T., Frost, D., Conroy, D., Evans, D.G., Lalloo, F., Eeles, R., Izatt, L., Davidson, R., Chu, C., Eccles, D., Selkirk, C.G., Daly, M., Isaacs, C., Stoppa-Lyonnet, D., Sinilnikova, O.M., Buecher, B., Belotti, M., Mazoyer, S., Barjhoux, L., Verny-Pierre, C., Lasset, C., Dreyfus, H., Pujol, P., Collonge-Rame, M.A., Rookus, M.A., Verhoef, S., Kriege, M., Hoogerbrugge, N., Ausems, M.G.E.M., Os, T.A. van, Wijnen, J., Devilee, P., Meijers-Heijboer, H.E.J., Blok, M.J., Heikkinen, T., Nevanlinna, H., Jakubowska, A., Lubinski, J., Huzarski, T., Byrski, T., Durocher, F., Couch, F.J., Lindor, N.M., Wang, X.S., Thomassen, M., Domchek, S., Nathanson, K., Caligo, M.A., Jernstrom, H., Liljegren, A., Ehrencrona, H., For, P.K., Ganz, P.A., Olopade, O.I., Tomlinson, G., Neuhausen, S., Antoniou, A.C., Chenevix-Trench, G., Rebbeck, T.R., GEMO Study Collaborators, SWE-BRCA
Published 2011

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2

by Osorio, A., Milne, R.L., Alonso, R., Pita, G., Peterlongo, P., Teule, A., Nathanson, K.L., Domchek, S.M., Rebbeck, T., Lasa, A., Konstantopoulou, I., Hogervorst, F.B., Verhoef, S., Dooren, M.F. van, Jager, A., Ausems, M.G.E.M., Aalfs, C.M., Asperen, C.J. van, Vreeswijk, M., Waisfisz, Q., Roozendaal, C.E. van, Ligtenberg, M.J., Easton, D.F., Peock, S., Cook, M., Oliver, C.T., Frost, D., Curzon, B., Evans, D.G., Lalloo, F., Eeles, R., Izatt, L., Davidson, R., Adlard, J., Eccles, D., Ong, K.R., Douglas, F., Downing, S., Brewer, C., Walker, L., Nevanlinna, H., Aittomaki, K., Couch, F.J., Fredericksen, Z., Lindor, N.M., Godwin, A., Isaacs, C., Caligo, M.A., Loman, N., Jernstrom, H., Barbany-Bustinza, G., Liljegren, A., Ehrencrona, H., Stenmark-Askmalm, M., Feliubadalo, L., Manoukian, S., Peissel, B., Zaffaroni, D., Bonanni, B., Fortuzzi, S., Johannsson, O.T., Chenevix-Trench, G., Chen, X.C., Beesley, J., Spurdle, A.B., Sinilnikova, O.M., Healey, S., McGuffog, L., Antoniou, A.C., Brunet, J., Radice, P., Benitez, J., HEBON, EMBRACE, SWE-BRCA, kConFab, CIMBA
Published 2011

Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study

by Brouckaert, O., Rudolph, A., Laenen, A., Keeman, R., Bolla, M.K., Wang, Q., Soubry, A., Wildiers, H., Andrulis, I.L., Arndt, V., Beckmann, M.W., Benitez, J., Blomqvist, C., Bojesen, S.E., Brauch, H., Brennan, P., Brenner, H., Chenevix-Trench, G., Choi, J.Y., Cornelissen, S., Couch, F.J., Cox, A., Cross, S.S., Czene, K., Eriksson, M., Fasching, P.A., Figueroa, J., Flyger, H., Giles, G.G., Gonzalez-Neira, A., Guenel, P., Hall, P., Hollestelle, A., Hopper, J.L., Ito, H., Jones, M., Kang, D., Knight, J.A., Kosma, V.M., Li, J.M., Lindblom, A., Lilyquist, J., Lophatananon, A., Mannermaa, A., Manoukian, S., Margolin, S., Matsuo, K., Muir, K., Nevanlinna, H., Peterlongo, P., Pylkas, K., Saajrang, S., Seynaeve, C., Shen, C.Y., Shu, X.O., Southey, M.C., Swerdlow, A., Teo, S.H., Tollenaar, R.A.E.M., Truong, T., Tseng, C.C., Broek, A.J. van den, Deurzen, C.H.M. van, Winqvist, R., Wu, A.H., Yip, C.H., Yu, J.C., Zheng, W., Milne, R.L., Pharoah, P.D.P., Easton, D.F., Schmidt, M.K., Garcia-Closas, M., Chang-Claude, J., Lambrechts, D., Neven, P., KConFab
Published 2017

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers

by Walker, L.C., Fredericksen, Z.S., Wang, X.S., Tarrell, R., Pankratz, V.S., Lindor, N.M., Beesley, J., Healey, S., Chen, X.Q., Fab, K.C., Stoppa-Lyonnet, D., Tirapo, C., Giraud, S., Mazoyer, S., Muller, D., Fricker, J.P., Delnatte, C., Schmutzler, R.K., Wappenschmidt, B., Engel, C., Schonbuchner, I., Deissler, H., Meindl, A., Hogervorst, F.B., Verheus, M., Hooning, M.J., Ouweland, A.M.W. van den, Nelen, M.R., Ausems, M.G.E.M., Aalfs, C.M., Asperen, C.J. van, Devilee, P., Gerrits, M.M., Waisfisz, Q., Szabo, C.I., Quad, M.S., Easton, D.F., Peock, S., Cook, M., Oliver, C.T., Frost, D., Harrington, P., Evans, D.G., Lalloo, F., Eeles, R., Izatt, L., Chu, C., Davidson, R., Eccles, D., Ong, K.R., Cook, J., Rebbeck, T., Nathanson, K.L., Domchek, S.M., Singer, C.F., Gschwantler-Kaulich, D., Dressler, A.C., Pfeiler, G., Godwin, A.K., Heikkinen, T., Nevanlinna, H., Agnarsson, B.A., Caligo, M.A., Olsson, H., Kristoffersson, U., Liljegren, A., Arver, B., Karlsson, P., Melin, B., Sinilnikova, O.M., McGuffog, L., Antoniou, A.C., Chenevix-Trench, G., Spurdle, A.B., Couch, F.J., Gemo Study Collaborators, HEBON, EMBRACE, SWE BRCA
Published 2010

Age- and Tumor Subtype Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers

by Schmidt, M.K., Hogervorst, F., Hien, R. van, Cornelissen, S., Broeks, A., Adank, M.A., Meijers, H., Waisfisz, Q., Hollestelle, A., Schutte, M., Ouweland, A. van den, Hooning, M., Andrulis, I.L., Anton-Culver, H., Antonenkova, N.N., Antoniou, A.C., Arndt, V., Bermisheva, M., Bogdanova, N.V., Bolla, M.K., Brauch, H., Brenner, H., Bruning, T., Burwinkel, B., Chang-Claude, J., Chenevix-Trench, G., Couch, F.J., Cox, A., Cross, S.S., Czene, K., Dunning, A.M., Fasching, P.A., Figueroa, J., Fletcher, O., Flyger, H., Galle, E., Garcia-Closas, M., Giles, G.G., Haeberle, L., Hall, P., Hillemanns, P., Hopper, J.L., Jakubowska, A., John, E.M., Jones, M., Khusnutdinova, E., Knight, J.A., Kosma, V.M., Kristensen, V., Lee, A., Lindblom, A., Lubinski, J., Mannermaa, A., Margolin, S., Meindl, A., Milne, R.L., Muranen, T.A., Newcomb, P.A., Offit, K., Park-Simon, T.W., Peto, J., Pharoah, P.D.P., Robson, M., Rudolph, A., Sawyer, E.J., Schmutzler, R.K., Seynaeve, C., Soens, J., Southey, M.C., Spurdle, A.B., Surowy, H., Swerdlow, A., Tollenaar, R.A.E.M., Tomlinson, I., Trentham-Dietz, A., Vachon, C., Wang, Q., Whittemore, A.S., Ziogas, A., Kolk, L. van der, Nevanlinna, H., Dork, T., Bojesen, S., Easton, D.F.
Published 2016

Fine-mapping of the 1p11.2 breast cancer susceptibility locus

by Horne H.N., Chung C.C., Zhang H., Yu K., Prokunina-Olsson L., Michailidou K., Bolla M.K., Wang Q., Dennis J., Hopper J.L., Southey M.C., Schmidt M.K., Broeks A., Muir K., Lophatananon A., Fasching P.A., Beckmann M.W., Fletcher O., Johnson N., Sawyer E.J., Tomlinson I., Burwinkel B., Marme F., Guénel P., Truong T., Bojesen S.E., Flyger H., Benitez J., González-Neira A., Anton-Culver H., Neuhausen S.L., Brenner H., Arndt V., Meindl A., Schmutzler R.K., Brauch H., Hamann U., Nevanlinna H., Khan S., Matsuo K., Iwata H., Dörk T., Bogdanova N.V., Lindblom A., Margolin S., Mannermaa A., Kosma V.-M., Chenevix-Trench G., Wu A.H., Ven Den Berg D., Smeets A., Zhao H., Chang-Claude J., Rudolph A., Radice P., Barile M., Couch F.J., Vachon C., Giles G.G., Milne R.L., Haiman C.A., Marchand L.L., Goldberg M.S., Teo S.H., Taib N.A.M., Kristensen V., Borresen-Dale A.-L., Zheng W., Shrubsole M., Winqvist R., Jukkola-Vuorinen A., Andrulis I.L., Knight J.A., Devilee P., Seynaeve C., García-Closas M., Czene K., Darabi H., Hollestelle A., Martens J.W.M., Li J., Lu W., Shu X.-O., Cox A., Cross S.S., Blot W., Cai Q., Shah M., Luccarini C., Baynes C., Harrington P., Kang D., Choi J.-Y., Hartman M., Chia K.S., Kabisch M., Torres D., Jakubowska A., Lubinski J., Sangrajrang S., Brennan P., Slager S., Yannoukakos D., Shen C.-Y., Hou M.-F., Swerdlow A., Orr N., Simard J., Hall P., Pharoah P.D.P., Easton D.F., Chanock S.J., Dunning A.M., Figueroa J.D.
Published 2018